Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/NEWRON-PHARMACEUTICALS-S--198001/news/Newron-prasentiert-Daten-der-Studie-014-015-und-Plane-fur-weitere-klinische-Entwicklung-von-Evena-46383418/?utm_source=whatsapp&utm_medium=social&utm_campaign=share